How many institutions held KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares in Q1 2021?

12 institutional investors reported KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares for Q1 2021. Use the holders table for investor-level position and value details.

KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA)

Q: What does CUSIP 48669G105 represent in this 13F holders report?

CUSIP 48669G105 is the security identifier for KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares used to aggregate holder disclosures.

CUSIP: 48669G105

Q1 2021 13F Holders as of 31 Mar 2021

Security type / class: Equity / American Depositary Shares
Total 13F shares: 467,061
Total 13F value: $4,601,637
Share change: -61,781
Put/Call ratio: 168%
SEC-reported price per share: $12.39
Number of holders: 12
Value change: -$368,945
Number of buys: 5
Number of sells: 7
Shares outstanding: 11,430,535

Security key

48669G105

Report period

Q1 2021

Institutions

Top holders

KZIA full security history Ownership snapshot Full 13F holder table KAZIA THERAPEUTICS LTD SEC filings KAZIA THERAPEUTICS LTD company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MORGAN STANLEY

Disclosed value leader

MORGAN STANLEY

Comparable rows

13/13

Latest evidence

31 Dec 2020

13F Lead comparable stake: 1.6% Showing 1-6 of 13 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 1.6%.

13 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.

Comparable ownership Top 5

MORGAN STANLEY 1.6%

Transform Wealth, LLC 0.93%

Atom Investors LP 0.87%

RENAISSANCE TECHNOLOGIES LLC 0.7%

TRUIST FINANCIAL CORP 0.31%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 13 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MORGAN STANLEY	13F Company 13F	1.6%	$1,551,000 179,600 shares	—	31 Dec 2020
Transform Wealth, LLC	13F Company 13F	0.93%	$95,000 106,245 shares	—	31 Dec 2020
Atom Investors LP	13F Company 13F	0.87%	$857,000 99,180 shares	—	31 Dec 2020
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	0.7%	$688,000 79,625 shares	—	31 Dec 2020
TRUIST FINANCIAL CORP	13F Company 13F	0.31%	$304,000 35,260 shares	—	31 Dec 2020
HighPoint Advisor Group LLC	13F Company 13F	0.28%	$368,000 32,435 shares	—	31 Dec 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

467,061

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q1 2021 value	Q1 2021 value	Value change	Value Chg %